FilingReader Intelligence
J.P. Morgan discloses Kangji Medical share dealings amid privatization
August 20, 2025 at 09:51 AM UTC•By FilingReader AI
J.P. Morgan Securities PLC disclosed dealings in Kangji Medical Holdings Limited shares on August 19, 2025, as a Class (5) associate connected with the offeror during an ongoing privatization.
The firm purchased 98,500 shares totaling $856,024 at prices between $8.64-$8.72, while selling 304,500 shares for $2.65m at $8.70 per share. The transactions were conducted for hedging Delta 1 products from client-driven orders.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
HKEX:9997•Hong Kong Exchange
News Alerts
Get instant email alerts when Kangji Medical Holdings publishes news
Free account required • Unsubscribe anytime